BOK Financial Private Wealth’s GSK GSK Stock Holding History

BOK Financial Private Wealth’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$89.1K	Hold	1,600	–	–	0.01%	227
2025 Q4	$79.2K	Hold	1,600	–	–	﹤0.01%	245
2025 Q3	$69.7K	Hold	1,600	–	–	﹤0.01%	229
2025 Q2	$62.1K	Sell	1,600 -112	-7%	-$4.28K	﹤0.01%	234
2025 Q1	$67.7K	Sell	1,712 -1,600	-48%	-$58.6K	0.01%	239
2024 Q4	$113K	Buy	3,312 +1	+0%	+$36	0.01%	199
2024 Q3	$137K	Buy	3,311 +1	+0%	+$41	0.01%	193
2024 Q2	$129K	Buy	3,310 +1	+0%	+$42	0.01%	190
2024 Q1	$143K	Buy	3,309 +1	+0%	+$41	0.01%	187
2023 Q4	$124K	Buy	3,308 +108	+3%	+$3.88K	0.01%	188
2023 Q3	$117K	Hold	3,200	–	–	0.01%	179
2023 Q2	$115K	Sell	3,200 -99	-3%	-$3.55K	0.01%	183
2023 Q1	$118K	Buy	3,299 +99	+3%	+$3.46K	0.01%	185
2022 Q4	$115K	Sell	3,200 -3,718	-54%	-$124K	0.01%	184
2022 Q3	$206K	Hold	6,918	–	–	0.02%	169
2022 Q2	$379K	Sell	6,918 -388	-5%	-$21.4K	0.03%	140
2022 Q1	$398K	Sell	7,306 -60	-0.8%	-$3.26K	0.03%	193
2021 Q4	$406K	Buy	+7,366	New	+$383K	0.03%	190

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BOK Financial Private Wealth's GSK Position: Q1 2026 in Review

BOK Financial Private Wealth held its GSK (GSK) position steady in Q1 2026 at 1,600 shares worth $89.1K. The position accounts for 0.01% of the portfolio, ranked #227.

BOK Financial Private Wealth first reported a position in GSK in Q4 2021 and has held it in 18 quarters since. The position peaked at $406K in Q4 2021. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

BOK Financial Private Wealth held 1,600 shares of GSK worth $89.1K as of Q1 2026.
BOK Financial Private Wealth left its GSK share count unchanged in Q1 2026.
GSK made up 0.01% of BOK Financial Private Wealth's portfolio in Q1 2026, its #227 holding.
BOK Financial Private Wealth first reported a position in GSK in Q4 2021 and has held it in 18 quarters since.
BOK Financial Private Wealth's GSK position peaked at $406K in Q4 2021.
1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on BOK Financial Private Wealth's 13F filing for Q1 2026, filed 12 May 2026.